ATE147625T1 - Hydantoin- oder imidazolidintrionderivate zur vorbeugung oder behandlung von niereninsuffizienz - Google Patents

Hydantoin- oder imidazolidintrionderivate zur vorbeugung oder behandlung von niereninsuffizienz

Info

Publication number
ATE147625T1
ATE147625T1 AT90810592T AT90810592T ATE147625T1 AT E147625 T1 ATE147625 T1 AT E147625T1 AT 90810592 T AT90810592 T AT 90810592T AT 90810592 T AT90810592 T AT 90810592T AT E147625 T1 ATE147625 T1 AT E147625T1
Authority
AT
Austria
Prior art keywords
preventing
hydantoin
intrion
imidazolide
derivatives
Prior art date
Application number
AT90810592T
Other languages
English (en)
Inventor
Hiroki C O Inst Of Bio- Mikami
Co Ltd - Kinashi Pharm
Kazuharu C O Inst Of Bi Ienaga
Original Assignee
Nippon Zoki Pharmaceutical Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nippon Zoki Pharmaceutical Co filed Critical Nippon Zoki Pharmaceutical Co
Application granted granted Critical
Publication of ATE147625T1 publication Critical patent/ATE147625T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Reproductive Health (AREA)
  • Urology & Nephrology (AREA)
  • Endocrinology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
AT90810592T 1989-08-09 1990-08-07 Hydantoin- oder imidazolidintrionderivate zur vorbeugung oder behandlung von niereninsuffizienz ATE147625T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP1207699A JP2678499B2 (ja) 1989-08-09 1989-08-09 尿毒症毒素低下剤

Publications (1)

Publication Number Publication Date
ATE147625T1 true ATE147625T1 (de) 1997-02-15

Family

ID=16544105

Family Applications (1)

Application Number Title Priority Date Filing Date
AT90810592T ATE147625T1 (de) 1989-08-09 1990-08-07 Hydantoin- oder imidazolidintrionderivate zur vorbeugung oder behandlung von niereninsuffizienz

Country Status (8)

Country Link
US (1) US5084473A (de)
EP (1) EP0412940B1 (de)
JP (1) JP2678499B2 (de)
KR (1) KR0151389B1 (de)
AT (1) ATE147625T1 (de)
DE (1) DE69029693T2 (de)
DK (1) DK0412940T3 (de)
ES (1) ES2095870T3 (de)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2678499B2 (ja) * 1989-08-09 1997-11-17 日本臓器製薬 株式会社 尿毒症毒素低下剤
US5912261A (en) * 1994-12-20 1999-06-15 Nippon Zoki Pharmaceutical Co., Ltd. Carboxyalkyl heterocyclic derivatives
US6197806B1 (en) 1995-12-20 2001-03-06 Nippon Zoki Pharmaceutical Co., Ltd. Eliminating agent for activated oxygen and free radicals
JPH10182460A (ja) * 1996-12-27 1998-07-07 Nippon Zoki Pharmaceut Co Ltd ３−デオキシグルコソン生成阻害剤
AU754989B2 (en) 1998-11-16 2002-11-28 Nippon Zoki Pharmaceutical Co., Ltd. A therapeutic agent for intractable vasculitis
JP4711523B2 (ja) * 2001-02-13 2011-06-29 日本臓器製薬株式会社 低アルブミン血症改善剤
TWI353979B (en) 2002-04-10 2011-12-11 Nippon Zoki Pharmaceutical Co Novel crystal form of 5-hydroxy-1-methylhydantoin
JP2004123736A (ja) * 2002-09-11 2004-04-22 Nippon Zoki Pharmaceut Co Ltd 光学活性（ｒ）−ヒダントイン誘導体
JP2004123735A (ja) * 2002-09-11 2004-04-22 Nippon Zoki Pharmaceut Co Ltd 光学活性（ｓ）−ヒダントイン誘導体
US20060241163A1 (en) * 2005-04-20 2006-10-26 Kaoru Okamoto Optically active (S)-hydantoin derivative
US20060241162A1 (en) * 2005-04-20 2006-10-26 Kaoru Okamoto Optically active (R)-hydantoin derivative
JP4674381B2 (ja) * 2005-12-13 2011-04-20 収 伊藤 複合オーニング装置及び複数キャンバスの巻取りローラ
JP4660616B2 (ja) * 2009-08-31 2011-03-30 株式会社東芝 基板検査装置
DK3111934T3 (da) * 2014-02-26 2021-11-15 Nippon Zoki Pharmaceutical Co Progressions-hæmmende eller -forbedrende middel til kronisk nyresygdom
WO2018230537A1 (ja) 2017-06-13 2018-12-20 国立研究開発法人国立がん研究センター 発がん抑制剤

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4248882A (en) * 1980-02-12 1981-02-03 Pfizer Inc. Treating diabetes-associated complications with hydantoin amines
AU578068B2 (en) * 1984-03-08 1988-10-13 Nippon Zoki Pharmaceutical Co., Ltd. Hydantoin derivatives and pharmaceutical compositions containing them
JPH062748B2 (ja) * 1984-03-08 1994-01-12 日本臓器製薬株式会社 新規ヒダントイン誘導体及び該化合物を有効成分として含有する医薬組成物
JPH0686436B2 (ja) * 1984-11-15 1994-11-02 日本臓器製薬株式会社 新規ヒダントイン誘導体及び該化合物を含有する医薬組成物
JPH0764729B2 (ja) * 1985-02-06 1995-07-12 日本臓器製薬株式会社 イミダゾリジントリオン誘導体を含有する医薬組成物
ATE50248T1 (de) * 1985-02-06 1990-02-15 Nippon Zoki Pharmaceutical Co Ein imidazolidintrion-derivat oder ein seiner pharmazeutisch akzeptierbaren salze enthaltende pharmazeutische zusammenstellung.
US4853401A (en) * 1987-04-01 1989-08-01 G. D. Searle & Co. Spiro-hydantoins as aldose reductase inhibitors
JP2678499B2 (ja) * 1989-08-09 1997-11-17 日本臓器製薬 株式会社 尿毒症毒素低下剤

Also Published As

Publication number Publication date
JPH0372463A (ja) 1991-03-27
ES2095870T3 (es) 1997-03-01
DE69029693T2 (de) 1997-05-07
DE69029693D1 (de) 1997-02-27
KR0151389B1 (ko) 1998-10-15
EP0412940B1 (de) 1997-01-15
JP2678499B2 (ja) 1997-11-17
US5084473A (en) 1992-01-28
EP0412940A2 (de) 1991-02-13
EP0412940A3 (en) 1991-10-23
KR910004191A (ko) 1991-03-28
DK0412940T3 (da) 1997-07-14

Similar Documents

Publication Publication Date Title
ATE147625T1 (de) Hydantoin- oder imidazolidintrionderivate zur vorbeugung oder behandlung von niereninsuffizienz
ES8603870A1 (es) Un procedimiento para la preparacion de derivados de 2,2'-iminobisetanol.
MX9306831A (es) Nuevos compuestos heterociclicos.
PT1029853E (pt) Derivados biciclicos heteroaromaticos uteis como agentes anticancerigenos
DE68924681D1 (de) Heterocyclische Biphosphonsäurederivate.
ATE227293T1 (de) 2,3-disubstituierte-(5,6)-heteroarylkondensiert - pyrimidin-4-one
DE68906609D1 (de) Dopamin-vorlaeufer.
PT97395A (pt) Processo para a preparacao de 2,9-di-substituidas-4h-pirido{1,2-a}-pirimidin-4-onas e de composicoes farmaceuticas que os contem
ES2100222T3 (es) Derivados del acido aminoalcansulfonico y compuestos farmaceuticos a utilizar para prevenir o tratar afecciones cardiacas.
DE69834500D1 (de) Xanthinderivative zur behandlung von hirnischämie
NO157643C (no) Anvendelse av sitronsyre for aa forhindre nedbrytning av farmasoeytisk taalbare syreaddisjonssalter av tienopyridinderivater.
DE3880564D1 (de) Arzneimittel zur behandlung von herzinsuffizienz.
PT91613A (pt) Process for the preparation of antihypertensive 3-piperidinyl-indazole derivatives
ITMI920082A1 (it) Derivati solforati di acidi biliari
ATE81466T1 (de) Verwendung von 2-oxo-imidazolidin-derivaten zur prophylaxe und zur behandlung von herzinsuffizienz.
FR2598914B1 (fr) Composition prophylactique et curative pour l'arteriosclerose
DK34882A (da) Fremgangsmaade til fremstilling af peptidderivater
ATE71091T1 (de) Tetrahydro-1,2,4-oxadiazin-5-thion-derivate.

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee